Apply to trial NCT06377371

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 4Diagnostic test

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.